2023-11-06T07:15:22-06:00 2022-12-31 260794367 UHY ADVISORS MID-ATLANTIC MD INC 8601 ROBERT FULTON DRIVE SUITE 210 COLUMBIA MD 21046 990 2022-01-01 752816066 THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION INC MESO 8773636376 1615 L ST NW 430 WASHINGTON DC 20036 DARCIENA ANDERSON CHRISTEL TREASURER 8773636376 2023-11-03 1 DARCIENA ANDERSON CHRISTEL 999009999 1 KATSIARYNA VASILIEV P02167272 4107205220 2023-11-03 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z DARCIENA ANDERSON CHRISTE 1615 L ST NW 430 WASHINGTON DC 20036 6269531 0 X WWW.CUREMESO.ORG X 1999 DC TO OFFER HOPE AND SUPPORT TO MESOTHELIOMA CANCER PATIENTS AND THEIR FAMILIES THROUGH EDUCATION, FUNDING OF QUALITY, PEER-REVIEWED RESEARCH, AND RAISE PUBLIC AWARENESS. 12 12 6 53 0 0 2386366 1243523 420000 671501 225159 -221948 0 140 3031525 1693216 399118 258341 0 0 564197 591945 0 0 141355 293855 340240 1257170 1190526 1774355 502690 9384474 9449879 304146 387325 9080328 9062554 X THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION, INC. MISSION IS TO OFFER HOPE AND SUPPORT TO PATIENTS AND FAMILIES DEALING WITH MESOTHELIOMA. THIS IS ACCOMPLISHED BY EDUCATING PATIENTS AND FAMILIES ABOUT THE DISEASE, HELPING THEM OBTAIN THE MOST UP-TO-DATE INFORMATION ON TREATMENT OPTIONS, CONNECTING THEM WITH MESOTHELIOMA TREATMENT SPECIALISTS, AND PROVIDING ASSISTANCE, EMOTIONAL SUPPORT, AND COMMUNITY WITH OTHERS. THE FOUNDATION PROVIDES FUNDING TO THE HIGHEST QUALITY AND MOST PROMISING MESOTHELIOMA RESEARCH PROJECTS WORLDWIDE THROUGH RIGOROUS PEER-REVIEW. THE FOUNDATION ALSO WORKS TO RAISE AWAREMESS OF THE DISEASE, AND ADVOCATES THAT THE PUBLIC AND PRIVATE SECTORS PARTNER IN THE EFFORT TO CURE IT BY DIRECTING THE RESOURCES NEEDED TO STOP THIS GLOBAL TRAGEDY. 0 0 515519 58341 671501 EDUCATION SUPPORT AND SYMPOSIUM - PATIENT SUPPORT SERVICES OFFERED BY THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION, INC. INCLUDE PERSONALIZED CONSULTATIONS AND GUIDANCE THROUGH TREATMENT WITH MESOTHELIOMA EXPERTS. THIS INCLUDES PROVIDING PATIENTS WITH INFORMATION ABOUT TREATMENT OPTIONS, CONNECTING THEM WITH MESOTHELIOMA TREATMENT SPECIALISTS WHEN NEEDED, AND FACILITATING ACCESS TO THE FOUNDATION'S SUPPORT GROUPS. 266295 200000 RESEARCH - THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION, INC. FUNDS THE MOST PROMISING MESOTHELIOMA RESEARCH PROJECTS GLOBALLY, AS DETERMINED BY A RIGOROUS PEER-REVIEW PROCESS VIA THE FOUNDATION'S SCIENCE ADVISORY BOARD AND APPROVED BY THE BOARD OF DIRECTORS. THIS PROCESS IS BASED UPON THE DEPARTMENT OF DEFENSE CDMRP. BASED UPON THE NATIONAL CANCER INSTITUTE, THE MESOTHELIOMA FOUNDATION HAS FUNDED 97 GRANTS, AWARDING $9.6 MILLION IN FUNDING RESEARCH GRANTS TO DATE. 33925 ADVOCACY - THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION, INC. ADVOCATES ON BEHALF OF ITS PATIENTS AND FAMILIES FOR INCREASED FUNDING OF MESOTHELIOMA RESEARCH THROUGH FEDERAL INVESTMENT. 815739 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 10 0 6 1 0 0 0 0 0 0 0 0 0 0 X 12 12 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 AK AL AR CA CO CT GA HI IL KS KY MA MD ME MN MS NC NJ NV NY OH OK OR PA RI SC TN VA WA WI WV NM X X THE ORGANIZATION 8773636376 1615 L STREET NW 430 WASHINGTON DC 20036 MARJORIE G ZAUDERER MD MS FACP CHAIR 1.00 X X 0 0 0 DARCIENA ANDERSON CHRISTEL TREASURER 1.00 X X 0 0 0 R TAYLOR RIPLEY MD SECRETARY 1.00 X X 0 0 0 KEITH CENGEL MD PHD DIRECTOR 1.00 X 0 0 0 JASON M FOSTER MD DIRECTOR 1.00 X 0 0 0 AARON S MANSFIELD MD DIRECTOR 1.00 X 0 0 0 SANJAY POPAT PHD DIRECTOR 1.00 X 0 0 0 BUERKLEY ROSE MSN RN DIRECTOR 1.00 X 0 0 0 BORIS SEPESI MD DIRECTOR 1.00 X 0 0 0 DANIEL STERMAN MD DIRECTOR 1.00 X 0 0 0 JAMES STEVENSON MD DIRECTOR 1.00 X 0 0 0 ANTOINETTE WOZNIAK MD DIRECTOR 1.00 X 0 0 0 WILLIAM N ZIEGLER DIRECTOR 1.00 X 0 0 0 PATRICK FORDE MD DIRECTOR 1.00 X 0 0 0 CHERYL BRUNER ESQ DIRECTOR 1.00 X 0 0 0 JESSICA BLACKFORD-CLEETON DIRECTOR 1.00 X 0 0 0 JULIE POWERS EXECUTIVE DIRECTOR 40.00 X 149525 0 7284 MAJA BELAMARIC COO 40.00 X 119308 0 5763 268833 0 13047 2 0 1 0 0 1243523 1243523 EDUCATIONAL PROGRAMMING 541900 650000 650000 SYMPOSIUM EVENTS 541900 21501 21501 671501 220837 220837 4133530 4576315 -442785 -442785 -442785 OTHER INCOME 900099 140 140 140 1693216 671641 0 -221948 125000 125000 58341 58341 75000 75000 281879 189012 48077 44790 188754 126568 32193 29993 11574 6516 3438 1620 69967 43701 15849 10417 39771 24542 9406 5823 41788 16400 21479 3909 48925 20614 24071 4240 11340 7662 2390 1288 36273 14296 14732 7245 19257 3488 2058 13711 58040 38780 10033 9227 23719 4715 19004 48 48 1255 1255 6661 4413 1165 1083 EVENTS 57878 51912 5966 BANK AND CREDIT CARD FE 17972 11285 6687 TELEPHONE 5990 1763 3932 295 DUES AND SUBSCRIPTIONS 5279 1132 3567 580 5815 1884 3484 447 1190526 815739 233432 141355 104896 322927 2851760 3511786 45698 10495 3172 10641 8688 3208 1953 6364340 5605964 4077 4077 9384474 9449879 29146 37325 275000 350000 304146 387325 X 9080328 9062554 9080328 9062554 9384474 9449879 502690 -456584 -63880 0 X X 0 0 0 X 1171628 1376144 5100939 2386366 1243523 11278600 1171628 1376144 5100939 2386366 1243523 11278600 952720 10325880 -34893 78039 65079 210606 220837 539668 64 3523 140 3727 11821995 0.87340 0.89060 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 10641 8688 1953 1953 X 1172752 -456584 -456584 1629336 63880 63880 1693216 1190526 0 1190526 0 1190526 PART X, LINE 2: THE INCOME TAX POSITIONS TAKEN BY THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION, INC. FOR ANY YEARS OPEN UNDER THE VARIOUS STATUTES OF LIMITATIONS ARE THAT THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION, INC. CONTINUES TO BE EXEMPT FROM INCOME TAXES AND THAT THEY HAVE PROPERLY REPORTED UNRELATED BUSINESS INCOME THAT IS SUBJECT TO INCOME TAXES. MANAGEMENT BELIEVES THAT THERE ARE NO TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN THAT WOULD SIGNIFICANTLY INCREASE WITHIN 12 MONTHS OF THE REPORTING DATE. THE FOUNDATION'S FEDERAL AND STATE INCOME TAX RETURNS ARE NOT CURRENTLY UNDER EXAMINATION. 0 EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, GRANTS TO RECIPIENTS RESEARCH 50000 EUROPE (INCLUDING ICELAND & GREENLAND) GRANTS TO RECIPIENTS RESEARCH 25000 0 0 0 0 0 0 75000 0 75000 EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, RESEARCH 50000 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 25000 WIRE 0 0 0 0 0 0 0 PART III ACCOUNTING METHOD: 1 NATIONAL CANCER INSTITUTE 10 CENTER DR BUILDING 10 BETHESDA MD 20892 0 25000 RESEARCH GRANT WAKE FOREST UNIVERSITY HEALTH SCIENCES MEDICAL CENTER BOULEVARD WINSTON SALEM NC 27157 223849199 0 25000 RESEARCH GRANT PATIENT TRAVEL 38 58341 X X 0 0 0 0 0 0 0 0 0 JULIE POWERS EXECUTIVE DIRECTOR 149525 0 0 0 0 0 0 0 7284 0 156809 0 0 0 PART I, LINE 3 EXECUTIVE COMPENSATION IS DETERMINED BY THE BOARD OF DIRECTORS BASED UPON THE EXECUTIVE DIRECTOR'S HISTORICAL COMPENSATION AND RELATIVELY MINOR AND INFREQUENT ADJUSTMENTS BASED UPON GROWTH, SUCCESS, AND INCREASING COMPLEXITY OF THE ORGANIZATION. CHANGES TO THE EXECUTIVE COMPENSATION ARE APPROVED IN THE MINUTES. FORM 990, PART VI, SECTION B, LINE 11B THE 990 IS REVIEWED AND APPROVED BY THE TREASURER AND EXECUTIVE DIRECTOR, THEN SUBMITTED TO THE FULL BOARD PRIOR TO BEING FILED. FORM 990, PART VI, SECTION B, LINE 12C CONFLICT OF INTEREST FORMS ARE REQUIRED TO BE FILLED OUT EACH YEAR AND ARE PUBLISHED IN THE BOARD OF DIRECTORS FOLDER AT EACH MEETING. FORM 990, PART VI, SECTION B, LINE 15A EXECUTIVE COMPENSATION IS DETERMINED BY THE BOARD OF DIRECTORS BASED UPON THE EXECUTIVE DIRECTOR'S HISTORICAL COMPENSATION AND RELATIVELY MINOR AND INFREQUENT ADJUSTMENTS BASED UPON GROWTH, SUCCESS, AND INCREASING COMPLEXITY OF THE ORGANIZATION. CHANGES TO THE EXECUTIVE COMPENSATION ARE APPROVED IN THE MINUTES. FORM 990, PART VI, SECTION C, LINE 19 THE GOVERNING DOCUMENTS ARE AVAILABLE AT THE ORGANIZATION'S OFFICE DURING BUSINESS HOURS, WITH AN APPOINTMENT AND BY REQUEST VIA EMAIL OR MAIL. FORM 990, PART XII, LINE 2C THE BOARD TREASURER OVERSEES THE SELECTION OF AN INDEPENDENT AUDITOR. THE OVERSIGHT AND SELECTION PROCESS DID NOT CHANGE FROM THE PRIOR YEAR.